Delivery Order SPE2DB24D1201-SPE2DB25FJDUY
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ibsrela 50 mg tablets (60-count units) under a firm fixed-price contract valued at $3,784.00, with completion targeted for September 18, 2025. This is a competitively awarded, non-set-aside delivery order issued by the federal government's medical procurement division. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ibsrela 50 mg tablets (60-count units) under a firm fixed-price contract valued at $21,030.84, with completion expected by August 21, 2025. This competitively awarded, non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ibsrela 50 mg tablets (60 tablets per unit) under a firm fixed-price contract valued at $26,774.18. This non-set-aside delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.31 to AmerisourceBergen Drug Corp for 60 tablets of Ibsrela 50 mg on June 27, 2025. This competitive award, issued without set-aside provisions, is structured as a firm fixed price delivery order with an ultimate completion date of June 30, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,909.82 to AmerisourceBergen Drug Corp for Ibsrela 50 mg tablets (60-count units) on September 3, 2025, with completion expected by September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $14,453.80 to AmerisourceBergen Drug Corp for the supply of Ibsrela 50 mg tablets (60-count units) on September 8, 2025, with completion targeted for September 9, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ibsrela 50 mg tablets (60-count unit) valued at $1,926.04. This firm fixed-price contract, which reaches completion on August 6, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Ibsrela 50 mg tablets (60-count units) with a ceiling value of $11,718.53. This firm fixed-price delivery order, which is due for completion by June 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made through competitive...
- The Defense Logistics Agency awarded a $3,431.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ibsrela 50 mg tablets (60-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be executed from the contractor's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $7,346.49 to AmerisourceBergen Drug Corp for the supply of Ibsrela 50 mg tablets (60-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...